rs150576537

Variant summary

Our verdict is Benign. The variant received -11 ACMG points: 2P and 13B. PM1BP4_StrongBP6BS1BS2

The NM_017739.4(POMGNT1):​c.301G>A​(p.Val101Ile) variant causes a missense change. The variant allele was found at a frequency of 0.00215 in 1,614,190 control chromosomes in the GnomAD database, including 34 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.0024 ( 6 hom., cov: 33)
Exomes 𝑓: 0.0021 ( 28 hom. )

Consequence

POMGNT1
NM_017739.4 missense

Scores

3
16

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:2B:13

Conservation

PhyloP100: 4.44

Publications

11 publications found
Variant links:
Genes affected
POMGNT1 (HGNC:19139): (protein O-linked mannose N-acetylglucosaminyltransferase 1 (beta 1,2-)) This gene encodes a type II transmembrane protein that resides in the Golgi apparatus. It participates in O-mannosyl glycosylation and is specific for alpha linked terminal mannose. Mutations in this gene may be associated with muscle-eye-brain disease and several congenital muscular dystrophies. Alternatively spliced transcript variants that encode different protein isoforms have been described. [provided by RefSeq, Feb 2014]
POMGNT1 Gene-Disease associations (from GenCC):
  • autosomal recessive limb-girdle muscular dystrophy type 2O
    Inheritance: AR Classification: DEFINITIVE, SUPPORTIVE, LIMITED Submitted by: Ambry Genetics, Orphanet, G2P
  • muscle-eye-brain disease
    Inheritance: AR Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, Myriad Women's Health
  • muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A3
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), Genomics England PanelApp, G2P, Ambry Genetics
  • muscular dystrophy-dystroglycanopathy (congenital with intellectual disability), type B3
    Inheritance: AR Classification: DEFINITIVE, LIMITED Submitted by: G2P, Ambry Genetics
  • myopathy caused by variation in POMGNT1
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • retinitis pigmentosa 76
    Inheritance: AR Classification: STRONG, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics
  • retinitis pigmentosa
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • congenital muscular dystrophy with cerebellar involvement
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • muscular dystrophy-dystroglycanopathy, type A
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_017739.4, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -11 ACMG points.

PM1
In a hotspot region, there are 2 aminoacids with missense pathogenic changes in the window of +-8 aminoacids around while only 2 benign, 15 uncertain in NM_017739.4
BP4
Computational evidence support a benign effect (MetaRNN=0.0067639947).
BP6
Variant 1-46196784-C-T is Benign according to our data. Variant chr1-46196784-C-T is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 95759.
BS1
Variant frequency is greater than expected in population amr. GnomAd4 allele frequency = 0.00245 (373/152348) while in subpopulation AMR AF = 0.00327 (50/15310). AF 95% confidence interval is 0.00254. There are 6 homozygotes in GnomAd4. There are 190 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 6 AR,AD gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_017739.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
POMGNT1
NM_017739.4
MANE Select
c.301G>Ap.Val101Ile
missense
Exon 4 of 22NP_060209.4Q8WZA1-1
POMGNT1
NM_001243766.2
c.301G>Ap.Val101Ile
missense
Exon 4 of 23NP_001230695.2Q8WZA1-2
POMGNT1
NM_001410783.1
c.301G>Ap.Val101Ile
missense
Exon 4 of 22NP_001397712.1A0A8I5KNB7

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
POMGNT1
ENST00000371984.8
TSL:1 MANE Select
c.301G>Ap.Val101Ile
missense
Exon 4 of 22ENSP00000361052.3Q8WZA1-1
POMGNT1
ENST00000371992.1
TSL:2
c.301G>Ap.Val101Ile
missense
Exon 4 of 23ENSP00000361060.1Q8WZA1-2
POMGNT1
ENST00000692369.1
c.301G>Ap.Val101Ile
missense
Exon 4 of 22ENSP00000508453.1A0A8I5KNB7

Frequencies

GnomAD3 genomes
AF:
0.00245
AC:
373
AN:
152230
Hom.:
6
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.000241
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00327
Gnomad ASJ
AF:
0.0470
Gnomad EAS
AF:
0.000385
Gnomad SAS
AF:
0.00124
Gnomad FIN
AF:
0.000659
Gnomad MID
AF:
0.00316
Gnomad NFE
AF:
0.00182
Gnomad OTH
AF:
0.00478
GnomAD2 exomes
AF:
0.00314
AC:
789
AN:
251406
AF XY:
0.00300
show subpopulations
Gnomad AFR exome
AF:
0.000185
Gnomad AMR exome
AF:
0.00116
Gnomad ASJ exome
AF:
0.0459
Gnomad EAS exome
AF:
0.0000544
Gnomad FIN exome
AF:
0.000185
Gnomad NFE exome
AF:
0.00207
Gnomad OTH exome
AF:
0.00408
GnomAD4 exome
AF:
0.00212
AC:
3098
AN:
1461842
Hom.:
28
Cov.:
33
AF XY:
0.00210
AC XY:
1526
AN XY:
727220
show subpopulations
African (AFR)
AF:
0.000209
AC:
7
AN:
33480
American (AMR)
AF:
0.00110
AC:
49
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.0450
AC:
1176
AN:
26136
East Asian (EAS)
AF:
0.0000252
AC:
1
AN:
39700
South Asian (SAS)
AF:
0.000684
AC:
59
AN:
86258
European-Finnish (FIN)
AF:
0.000431
AC:
23
AN:
53374
Middle Eastern (MID)
AF:
0.00260
AC:
15
AN:
5768
European-Non Finnish (NFE)
AF:
0.00137
AC:
1523
AN:
1112008
Other (OTH)
AF:
0.00406
AC:
245
AN:
60394
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.477
Heterozygous variant carriers
0
279
559
838
1118
1397
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
66
132
198
264
330
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00245
AC:
373
AN:
152348
Hom.:
6
Cov.:
33
AF XY:
0.00255
AC XY:
190
AN XY:
74502
show subpopulations
African (AFR)
AF:
0.000241
AC:
10
AN:
41576
American (AMR)
AF:
0.00327
AC:
50
AN:
15310
Ashkenazi Jewish (ASJ)
AF:
0.0470
AC:
163
AN:
3470
East Asian (EAS)
AF:
0.000386
AC:
2
AN:
5184
South Asian (SAS)
AF:
0.00124
AC:
6
AN:
4834
European-Finnish (FIN)
AF:
0.000659
AC:
7
AN:
10628
Middle Eastern (MID)
AF:
0.00340
AC:
1
AN:
294
European-Non Finnish (NFE)
AF:
0.00182
AC:
124
AN:
68028
Other (OTH)
AF:
0.00473
AC:
10
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.507
Heterozygous variant carriers
0
18
37
55
74
92
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00361
Hom.:
10
Bravo
AF:
0.00234
Asia WGS
AF:
0.000289
AC:
1
AN:
3478
EpiCase
AF:
0.00278
EpiControl
AF:
0.00225

ClinVar

ClinVar submissions
Significance:Conflicting classifications of pathogenicity
Revision:criteria provided, conflicting classifications
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
5
not provided (5)
-
-
3
not specified (3)
-
-
2
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A3 (2)
-
1
-
Autosomal recessive limb-girdle muscular dystrophy type 2O (1)
-
1
-
Congenital Muscular Dystrophy, alpha-dystroglycan related (1)
-
-
1
Muscle eye brain disease (1)
-
-
1
Muscular dystrophy-dystroglycanopathy (congenital with intellectual disability), type B3;C3150417:Autosomal recessive limb-girdle muscular dystrophy type 2O (1)
-
-
1
POMGNT1-related disorder (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.073
BayesDel_addAF
Benign
-0.51
T
BayesDel_noAF
Benign
-0.51
CADD
Benign
20
DANN
Benign
0.82
DEOGEN2
Benign
0.0025
T
Eigen
Benign
-0.43
Eigen_PC
Benign
-0.19
FATHMM_MKL
Uncertain
0.81
D
LIST_S2
Uncertain
0.93
D
M_CAP
Benign
0.017
T
MetaRNN
Benign
0.0068
T
MetaSVM
Benign
-0.87
T
MutationAssessor
Benign
-0.51
N
PhyloP100
4.4
PrimateAI
Uncertain
0.68
T
PROVEAN
Benign
0.41
N
REVEL
Benign
0.088
Sift
Benign
1.0
T
Sift4G
Benign
1.0
T
Varity_R
0.15
gMVP
0.16
Mutation Taster
=98/2
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

dbSNP: rs150576537;
hg19: chr1-46662456;
COSMIC: COSV64339613;
COSMIC: COSV64339613;
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.